Cantor Fitzgerald Cuts Intel (NASDAQ:INTC) Price Target to $125.00
Intel (NASDAQ:INTC – Free Report) had its target price cut by Cantor Fitzgerald from $150.00 to $125.00 in a research report released on Friday, MarketBeat reports. They currently have a neutral rating on the chip maker’s stock. INTC has been the topic of a number of other reports. The Goldman Sachs Group reissued a “neutral” […]
Sanford C. Bernstein Cuts Intuitive Surgical (NASDAQ:ISRG) Price Target to $685.00
Intuitive Surgical (NASDAQ:ISRG – Free Report) had its price objective reduced by Sanford C. Bernstein from $750.00 to $685.00 in a research note released on Friday morning,Benzinga reports. They currently have an outperform rating on the medical equipment provider’s stock. ISRG has been the topic of several other research reports. The Goldman Sachs Group set […]
BTIG Research Cuts Intuitive Surgical (NASDAQ:ISRG) Price Target to $469.00
Intuitive Surgical (NASDAQ:ISRG – Free Report) had its price objective decreased by BTIG Research from $512.00 to $469.00 in a research report released on Friday morning, MarketBeat Ratings reports. BTIG Research currently has a buy rating on the medical equipment provider’s stock. ISRG has been the subject of several other reports. Zacks Research lowered shares […]
Intuitive Surgical (NASDAQ:ISRG) Price Target Cut to $510.00 by Analysts at Truist Financial
Intuitive Surgical (NASDAQ:ISRG – Get Free Report) had its price objective dropped by research analysts at Truist Financial from $580.00 to $510.00 in a report released on Thursday,Benzinga reports. The brokerage currently has a “buy” rating on the medical equipment provider’s stock. Truist Financial’s price target indicates a potential upside of 27.91% from the stock’s […]
TD Cowen Cuts Intuitive Surgical (NASDAQ:ISRG) Price Target to $520.00
Intuitive Surgical (NASDAQ:ISRG – Get Free Report) had its price target cut by research analysts at TD Cowen from $585.00 to $520.00 in a note issued to investors on Monday,Benzinga reports. The brokerage presently has a “buy” rating on the medical equipment provider’s stock. TD Cowen’s price objective would suggest a potential upside of 26.88% […]
last updated on 27 Jul 08:39